Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | +6.52% | -4.52% | -84.91% |
Financials (USD)
Sales 2024 * | 193M | Sales 2025 * | 285M | Capitalization | 376M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -235M | EV / Sales 2024 * | 4.18 x |
Net Debt 2024 * | 432M | Net Debt 2025 * | 502M | EV / Sales 2025 * | 3.08 x |
P/E ratio 2024 * |
-1.33
x | P/E ratio 2025 * |
-1.64
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | +3.26% | ||
1 week | -5.48% | ||
Current month | -63.20% | ||
1 month | -61.77% | ||
3 months | -80.56% | ||
6 months | -79.46% | ||
Current year | -85.93% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.47 | +6.52% | 7 455 408 |
24-04-25 | 1.38 | +1.47% | 9,989,457 |
24-04-24 | 1.36 | -7.48% | 11,064,874 |
24-04-23 | 1.47 | -5.77% | 9,818,090 |
24-04-22 | 1.56 | +0.65% | 8,964,453 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.93% | 376M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.42% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- PACB Stock